A citation-based method for searching scientific literature

Oliver Biehlmaier, Mesbah Alam, Werner J Schmidt. Neurochem Int 2007
Times Cited: 27







List of co-cited articles
187 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
33

Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
Nicolás Cuenca, María-Trinidad Herrero, Antonia Angulo, Emilio de Juan, Gema C Martínez-Navarrete, Salvador López, Carlos Barcia, José Martín-Nieto. J Comp Neurol 2005
40
29

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
241
29

Retinal nerve fiber layer thinning in Parkinson disease.
Rivka Inzelberg, Jose Antonio Ramirez, Puiu Nisipeanu, Avinoam Ophir. Vision Res 2004
216
25

Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.
Julián Esteve-Rudd, Laura Fernández-Sánchez, Pedro Lax, Emilio De Juan, José Martín-Nieto, Nicolás Cuenca. Neurobiol Dis 2011
33
25


MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells.
W G Tatton, M M Kwan, M C Verrier, N A Seniuk, E Theriault. Brain Res 1990
76
22


Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Ranjita Betarbet, Rosa M Canet-Aviles, Todd B Sherer, Pier G Mastroberardino, Chris McLendon, Jin-Ho Kim, Serena Lund, Hye-Mee Na, Georgia Taylor, Neil F Bence,[...]. Neurobiol Dis 2006
224
18


Alpha synuclein gene expression profile in the retina of vertebrates.
Gema C Martínez-Navarrete, José Martín-Nieto, Julián Esteve-Rudd, Antonia Angulo, Nicolás Cuenca. Mol Vis 2007
57
18

Dopamine and retinal function.
Paul Witkovsky. Doc Ophthalmol 2004
501
18

The retina in Parkinson's disease.
Neil K Archibald, Michael P Clarke, Urs P Mosimann, David J Burn. Brain 2009
213
18

Inner retinal layer thinning in Parkinson disease.
Mohammedyusuf E Hajee, Wayne F March, Douglas R Lazzaro, Arthur H Wolintz, Eric M Shrier, Sofya Glazman, Ivan G Bodis-Wollner. Arch Ophthalmol 2009
176
18

The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Eduardo Maria Normando, Benjamin Michael Davis, Lies De Groef, Shereen Nizari, Lisa A Turner, Nivedita Ravindran, Milena Pahlitzsch, Jonathan Brenton, Giulia Malaguarnera, Li Guo,[...]. Acta Neuropathol Commun 2016
56
18

Mechanism of toxicity in rotenone models of Parkinson's disease.
Todd B Sherer, Ranjita Betarbet, Claudia M Testa, Byoung Boo Seo, Jason R Richardson, Jin Ho Kim, Gary W Miller, Takao Yagi, Akemi Matsuno-Yagi, J Timothy Greenamyre. J Neurosci 2003
556
14

Neurobiology of retinal dopamine in relation to degenerative states of the tissue.
M B Djamgoz, M W Hankins, J Hirano, S N Archer. Vision Res 1997
194
14



Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.
Robert E Drolet, Jason R Cannon, Laura Montero, J Timothy Greenamyre. Neurobiol Dis 2009
133
14

Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
M F Ghilardi, E Chung, I Bodis-Wollner, M Dvorzniak, A Glover, M Onofrj. Life Sci 1988
44
14

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Christopher R Adam, Eric Shrier, Yin Ding, Sofya Glazman, Ivan Bodis-Wollner. J Neuroophthalmol 2013
59
14

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
Barbara Nowacka, Wojciech Lubiński, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Doc Ophthalmol 2015
24
16

Visual dysfunction in Parkinson's disease.
Rimona S Weil, Anette E Schrag, Jason D Warren, Sebastian J Crutch, Andrew J Lees, Huw R Morris. Brain 2016
163
14

Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.
Li Guo, Eduardo M Normando, Parth Arvind Shah, Lies De Groef, M Francesca Cordeiro. Mov Disord 2018
35
14

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living.
J M Gorell, C C Johnson, B A Rybicki, E L Peterson, R J Richardson. Neurology 1998
446
11

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
11



An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Todd B Sherer, Ranjita Betarbet, Amy K Stout, Serena Lund, Melisa Baptista, Alexander V Panov, Mark R Cookson, J Timothy Greenamyre. J Neurosci 2002
407
11

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.
Hui-Ming Gao, Jau-Shyong Hong, Wanqin Zhang, Bin Liu. J Neurosci 2002
330
11

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
Heiko Braak, Kelly Del Tredici, Hansjürgen Bratzke, John Hamm-Clement, Daniele Sandmann-Keil, Udo Rüb. J Neurol 2002
378
11

Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain.
Valentina Bashkatova, Mesbah Alam, Anatoly Vanin, Werner J Schmidt. Exp Neurol 2004
65
11

Neuropsychological and perceptual defects in Parkinson's disease.
Ivan Bodis-Wollner. Parkinsonism Relat Disord 2003
75
11



The effect of intraocular 6-hydroxydopamine on retinal processing of primates.
M F Ghilardi, M S Marx, I Bodis-Wollner, C B Camras, A A Glover. Ann Neurol 1989
48
11




Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.
Julián Esteve-Rudd, Laura Campello, María-Trinidad Herrero, Nicolás Cuenca, José Martín-Nieto. Brain Res 2010
35
11

Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
M J Price, R G Feldman, D Adelberg, H Kayne. Neurology 1992
171
11

Retinopathy in Parkinson Disease.
Ivan Bodis-Wollner. J Neural Transm (Vienna) 2009
97
11

A highly reproducible rotenone model of Parkinson's disease.
Jason R Cannon, Victor Tapias, Hye Mee Na, Anthony S Honick, Robert E Drolet, J Timothy Greenamyre. Neurobiol Dis 2009
400
11

Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Bimla Nehru, Ranjeet Verma, Pooja Khanna, Suresh Kumar Sharma. Brain Res 2008
32
11


The possible role of retinal dopaminergic system in visual performance.
R Brandies, S Yehuda. Neurosci Biobehav Rev 2008
58
11

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Claudia M Testa, Todd B Sherer, J Timothy Greenamyre. Brain Res Mol Brain Res 2005
171
11

Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
Masatoshi Inden, Yoshihisa Kitamura, Hiroki Takeuchi, Takashi Yanagida, Kazuyuki Takata, Yuka Kobayashi, Takashi Taniguchi, Kanji Yoshimoto, Masahiko Kaneko, Yasunobu Okuma,[...]. J Neurochem 2007
154
11

Pesticide/environmental exposures and Parkinson's disease in East Texas.
Amanpreet S Dhillon, G Lester Tarbutton, Jeffrey L Levin, George M Plotkin, Larry K Lowry, J Torey Nalbone, Sara Shepherd. J Agromedicine 2008
123
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.